Tectonic Therapeutic, Inc. current report, 04 June 2020

Business Context and Reporting Period

This Form 8-K filing by AVROBIO, Inc. (not Tectonic Therapeutic, Inc.) reports on the results of its 2020 Annual Meeting of Stockholders held on June 4, 2020. The company is an emerging growth company incorporated in Delaware, with its principal executive offices in Cambridge, MA.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results and does not contain financial performance data.

Material Changes and Voting Results

Stockholders voted on three proposals at the Annual Meeting. The results were as follows:

  • Election of Directors: Stockholders elected two Class II director nominees to serve until the 2023 annual meeting:
    • Ian Clark: 19,402,202 votes For; 11,160,529 votes Withheld.
    • Annalisa Jenkins, M.B.B.S., F.R.C.P.: 25,186,686 votes For; 5,376,045 votes Withheld.
  • Ratification of Auditors: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2020.
    • Votes For: 34,618,405
    • Votes Against: 19,412
    • Abstentions: 1,740
  • Stock Plan Amendment: Stockholders approved an amendment to the AVROBIO, Inc. 2018 Stock Option and Incentive Plan.
    • Votes For: 24,179,440
    • Votes Against: 6,377,237
    • Abstentions: 6,054

Guidance, Outlook, and Risks

The filing text does not provide guidance, outlook, management commentary on future operations, specific risks, contingencies, or unusual items. The document is limited to the submission of matters to a vote of security holders.

Important Facts for Investors to Verify

  • Verify the significant number of votes withheld for director nominee Ian Clark (approx. 36% of votes cast) compared to Annalisa Jenkins (approx. 18% withheld).
  • Confirm the details of the "First Amendment to the AVROBIO, Inc. 2018 Stock Option and Incentive Plan" referenced in Exhibit 10.1 to understand the specific changes to equity compensation.
  • Note the discrepancy between the request metadata (Tectonic Therapeutic) and the actual filing registrant (AVROBIO, Inc.).